Loading…
Breast Cancer Subtypes in Patients Aged 70 Years and Older
Recurrence and survival pattern in breast cancer (bc) patients (pts) ≥ 70 years subcategorized according to subtype and age are still an area of uncertainty. Tumor characteristics, patient demographics, therapies applied, and recurrence pattern were compared between luminal A (LA), luminal B (LB), H...
Saved in:
Published in: | Cancer investigation 2016-05, Vol.34 (5), p.197-204 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c366t-ba446be0a6e4349bedc95f30ef2ad742b2aaecc7bd54f716fe4a9d2a58df58913 |
---|---|
cites | cdi_FETCH-LOGICAL-c366t-ba446be0a6e4349bedc95f30ef2ad742b2aaecc7bd54f716fe4a9d2a58df58913 |
container_end_page | 204 |
container_issue | 5 |
container_start_page | 197 |
container_title | Cancer investigation |
container_volume | 34 |
creator | Königsberg, Robert Pfeiler, Georg Hammerschmid, Nicole Holub, Oliver Glössmann, Kerstin Larcher-Senn, Julian Dittrich, Christian |
description | Recurrence and survival pattern in breast cancer (bc) patients (pts) ≥ 70 years subcategorized according to subtype and age are still an area of uncertainty. Tumor characteristics, patient demographics, therapies applied, and recurrence pattern were compared between luminal A (LA), luminal B (LB), Her2/neu overexpressing (Her+) and triple-negative (TN) bc subtypes and the age subcategories 70-74, 75-79, ≥80 years. Based on univariate Cox-regression-analyses distant-disease-free-survival (DDFS) differed significantly for bc subtypes (p = 0.0002), notably for Her+ vs. LA (p = 0.0014), TN vs. LA (p < 0.001), and TN vs. LB (p = 0.0086). Not age, but Her+ and TN represented prognostic factors for DDFS. |
doi_str_mv | 10.1080/07357907.2016.1182184 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmed_primary_27215407</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1793566111</sourcerecordid><originalsourceid>FETCH-LOGICAL-c366t-ba446be0a6e4349bedc95f30ef2ad742b2aaecc7bd54f716fe4a9d2a58df58913</originalsourceid><addsrcrecordid>eNp90D1PwzAQgGELgWgp_ASQR5YU27HjhIlS8SVVKhIwMFmX-IyC8lHsRKj_nkQtjEy3PHcnvYScczbnLGVXTMdKZ0zPBePJnPNU8FQekClXsYgkz8QhmY4mGtGEnITwydigtDomE6EFV5LpKbm-9Qiho0toCvT0pc-77QYDLRv6DF2JTRfo4gMt1Yy-I_hAobF0XVn0p-TIQRXwbD9n5O3-7nX5GK3WD0_LxSoq4iTpohykTHJkkKCMZZajLTLlYoZOgNVS5AIAi0LnVkmneeJQQmYFqNQ6lWY8npHL3d2Nb796DJ2py1BgVUGDbR8M11mskoTzkaodLXwbgkdnNr6swW8NZ2bMZn6zmTGb2Wcb9i72L_q8Rvu39dtpADc7UDau9TV8t76ypoNt1Xrnh3ZlMPH_P34A4DJ66A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1793566111</pqid></control><display><type>article</type><title>Breast Cancer Subtypes in Patients Aged 70 Years and Older</title><source>Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)</source><creator>Königsberg, Robert ; Pfeiler, Georg ; Hammerschmid, Nicole ; Holub, Oliver ; Glössmann, Kerstin ; Larcher-Senn, Julian ; Dittrich, Christian</creator><creatorcontrib>Königsberg, Robert ; Pfeiler, Georg ; Hammerschmid, Nicole ; Holub, Oliver ; Glössmann, Kerstin ; Larcher-Senn, Julian ; Dittrich, Christian</creatorcontrib><description>Recurrence and survival pattern in breast cancer (bc) patients (pts) ≥ 70 years subcategorized according to subtype and age are still an area of uncertainty. Tumor characteristics, patient demographics, therapies applied, and recurrence pattern were compared between luminal A (LA), luminal B (LB), Her2/neu overexpressing (Her+) and triple-negative (TN) bc subtypes and the age subcategories 70-74, 75-79, ≥80 years. Based on univariate Cox-regression-analyses distant-disease-free-survival (DDFS) differed significantly for bc subtypes (p = 0.0002), notably for Her+ vs. LA (p = 0.0014), TN vs. LA (p < 0.001), and TN vs. LB (p = 0.0086). Not age, but Her+ and TN represented prognostic factors for DDFS.</description><identifier>ISSN: 0735-7907</identifier><identifier>EISSN: 1532-4192</identifier><identifier>DOI: 10.1080/07357907.2016.1182184</identifier><identifier>PMID: 27215407</identifier><language>eng</language><publisher>England: Taylor & Francis</publisher><subject>adjuvant therapies ; Age categories ; Age Factors ; Aged ; Aged, 80 and over ; Biomarkers, Tumor ; breast cancer subtypes ; Breast Neoplasms - diagnosis ; Breast Neoplasms - mortality ; Breast Neoplasms - therapy ; Combined Modality Therapy ; DDFS ; Elderly patients ; Female ; Humans ; Immunohistochemistry ; LRFS ; Neoplasm Grading ; Neoplasm Metastasis ; Neoplasm Recurrence, Local ; Neoplasm Staging ; Prognosis ; Proportional Hazards Models ; Retrospective Studies ; Treatment Outcome ; Tumor Burden</subject><ispartof>Cancer investigation, 2016-05, Vol.34 (5), p.197-204</ispartof><rights>2016 Taylor & Francis Group, LLC 2016</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c366t-ba446be0a6e4349bedc95f30ef2ad742b2aaecc7bd54f716fe4a9d2a58df58913</citedby><cites>FETCH-LOGICAL-c366t-ba446be0a6e4349bedc95f30ef2ad742b2aaecc7bd54f716fe4a9d2a58df58913</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27215407$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Königsberg, Robert</creatorcontrib><creatorcontrib>Pfeiler, Georg</creatorcontrib><creatorcontrib>Hammerschmid, Nicole</creatorcontrib><creatorcontrib>Holub, Oliver</creatorcontrib><creatorcontrib>Glössmann, Kerstin</creatorcontrib><creatorcontrib>Larcher-Senn, Julian</creatorcontrib><creatorcontrib>Dittrich, Christian</creatorcontrib><title>Breast Cancer Subtypes in Patients Aged 70 Years and Older</title><title>Cancer investigation</title><addtitle>Cancer Invest</addtitle><description>Recurrence and survival pattern in breast cancer (bc) patients (pts) ≥ 70 years subcategorized according to subtype and age are still an area of uncertainty. Tumor characteristics, patient demographics, therapies applied, and recurrence pattern were compared between luminal A (LA), luminal B (LB), Her2/neu overexpressing (Her+) and triple-negative (TN) bc subtypes and the age subcategories 70-74, 75-79, ≥80 years. Based on univariate Cox-regression-analyses distant-disease-free-survival (DDFS) differed significantly for bc subtypes (p = 0.0002), notably for Her+ vs. LA (p = 0.0014), TN vs. LA (p < 0.001), and TN vs. LB (p = 0.0086). Not age, but Her+ and TN represented prognostic factors for DDFS.</description><subject>adjuvant therapies</subject><subject>Age categories</subject><subject>Age Factors</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biomarkers, Tumor</subject><subject>breast cancer subtypes</subject><subject>Breast Neoplasms - diagnosis</subject><subject>Breast Neoplasms - mortality</subject><subject>Breast Neoplasms - therapy</subject><subject>Combined Modality Therapy</subject><subject>DDFS</subject><subject>Elderly patients</subject><subject>Female</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>LRFS</subject><subject>Neoplasm Grading</subject><subject>Neoplasm Metastasis</subject><subject>Neoplasm Recurrence, Local</subject><subject>Neoplasm Staging</subject><subject>Prognosis</subject><subject>Proportional Hazards Models</subject><subject>Retrospective Studies</subject><subject>Treatment Outcome</subject><subject>Tumor Burden</subject><issn>0735-7907</issn><issn>1532-4192</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNp90D1PwzAQgGELgWgp_ASQR5YU27HjhIlS8SVVKhIwMFmX-IyC8lHsRKj_nkQtjEy3PHcnvYScczbnLGVXTMdKZ0zPBePJnPNU8FQekClXsYgkz8QhmY4mGtGEnITwydigtDomE6EFV5LpKbm-9Qiho0toCvT0pc-77QYDLRv6DF2JTRfo4gMt1Yy-I_hAobF0XVn0p-TIQRXwbD9n5O3-7nX5GK3WD0_LxSoq4iTpohykTHJkkKCMZZajLTLlYoZOgNVS5AIAi0LnVkmneeJQQmYFqNQ6lWY8npHL3d2Nb796DJ2py1BgVUGDbR8M11mskoTzkaodLXwbgkdnNr6swW8NZ2bMZn6zmTGb2Wcb9i72L_q8Rvu39dtpADc7UDau9TV8t76ypoNt1Xrnh3ZlMPH_P34A4DJ66A</recordid><startdate>20160527</startdate><enddate>20160527</enddate><creator>Königsberg, Robert</creator><creator>Pfeiler, Georg</creator><creator>Hammerschmid, Nicole</creator><creator>Holub, Oliver</creator><creator>Glössmann, Kerstin</creator><creator>Larcher-Senn, Julian</creator><creator>Dittrich, Christian</creator><general>Taylor & Francis</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20160527</creationdate><title>Breast Cancer Subtypes in Patients Aged 70 Years and Older</title><author>Königsberg, Robert ; Pfeiler, Georg ; Hammerschmid, Nicole ; Holub, Oliver ; Glössmann, Kerstin ; Larcher-Senn, Julian ; Dittrich, Christian</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c366t-ba446be0a6e4349bedc95f30ef2ad742b2aaecc7bd54f716fe4a9d2a58df58913</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>adjuvant therapies</topic><topic>Age categories</topic><topic>Age Factors</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biomarkers, Tumor</topic><topic>breast cancer subtypes</topic><topic>Breast Neoplasms - diagnosis</topic><topic>Breast Neoplasms - mortality</topic><topic>Breast Neoplasms - therapy</topic><topic>Combined Modality Therapy</topic><topic>DDFS</topic><topic>Elderly patients</topic><topic>Female</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>LRFS</topic><topic>Neoplasm Grading</topic><topic>Neoplasm Metastasis</topic><topic>Neoplasm Recurrence, Local</topic><topic>Neoplasm Staging</topic><topic>Prognosis</topic><topic>Proportional Hazards Models</topic><topic>Retrospective Studies</topic><topic>Treatment Outcome</topic><topic>Tumor Burden</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Königsberg, Robert</creatorcontrib><creatorcontrib>Pfeiler, Georg</creatorcontrib><creatorcontrib>Hammerschmid, Nicole</creatorcontrib><creatorcontrib>Holub, Oliver</creatorcontrib><creatorcontrib>Glössmann, Kerstin</creatorcontrib><creatorcontrib>Larcher-Senn, Julian</creatorcontrib><creatorcontrib>Dittrich, Christian</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer investigation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Königsberg, Robert</au><au>Pfeiler, Georg</au><au>Hammerschmid, Nicole</au><au>Holub, Oliver</au><au>Glössmann, Kerstin</au><au>Larcher-Senn, Julian</au><au>Dittrich, Christian</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Breast Cancer Subtypes in Patients Aged 70 Years and Older</atitle><jtitle>Cancer investigation</jtitle><addtitle>Cancer Invest</addtitle><date>2016-05-27</date><risdate>2016</risdate><volume>34</volume><issue>5</issue><spage>197</spage><epage>204</epage><pages>197-204</pages><issn>0735-7907</issn><eissn>1532-4192</eissn><abstract>Recurrence and survival pattern in breast cancer (bc) patients (pts) ≥ 70 years subcategorized according to subtype and age are still an area of uncertainty. Tumor characteristics, patient demographics, therapies applied, and recurrence pattern were compared between luminal A (LA), luminal B (LB), Her2/neu overexpressing (Her+) and triple-negative (TN) bc subtypes and the age subcategories 70-74, 75-79, ≥80 years. Based on univariate Cox-regression-analyses distant-disease-free-survival (DDFS) differed significantly for bc subtypes (p = 0.0002), notably for Her+ vs. LA (p = 0.0014), TN vs. LA (p < 0.001), and TN vs. LB (p = 0.0086). Not age, but Her+ and TN represented prognostic factors for DDFS.</abstract><cop>England</cop><pub>Taylor & Francis</pub><pmid>27215407</pmid><doi>10.1080/07357907.2016.1182184</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0735-7907 |
ispartof | Cancer investigation, 2016-05, Vol.34 (5), p.197-204 |
issn | 0735-7907 1532-4192 |
language | eng |
recordid | cdi_pubmed_primary_27215407 |
source | Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list) |
subjects | adjuvant therapies Age categories Age Factors Aged Aged, 80 and over Biomarkers, Tumor breast cancer subtypes Breast Neoplasms - diagnosis Breast Neoplasms - mortality Breast Neoplasms - therapy Combined Modality Therapy DDFS Elderly patients Female Humans Immunohistochemistry LRFS Neoplasm Grading Neoplasm Metastasis Neoplasm Recurrence, Local Neoplasm Staging Prognosis Proportional Hazards Models Retrospective Studies Treatment Outcome Tumor Burden |
title | Breast Cancer Subtypes in Patients Aged 70 Years and Older |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T08%3A27%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Breast%20Cancer%20Subtypes%20in%20Patients%20Aged%2070%20Years%20and%20Older&rft.jtitle=Cancer%20investigation&rft.au=K%C3%B6nigsberg,%20Robert&rft.date=2016-05-27&rft.volume=34&rft.issue=5&rft.spage=197&rft.epage=204&rft.pages=197-204&rft.issn=0735-7907&rft.eissn=1532-4192&rft_id=info:doi/10.1080/07357907.2016.1182184&rft_dat=%3Cproquest_pubme%3E1793566111%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c366t-ba446be0a6e4349bedc95f30ef2ad742b2aaecc7bd54f716fe4a9d2a58df58913%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1793566111&rft_id=info:pmid/27215407&rfr_iscdi=true |